Xenter Secures $58.25 Million in Series B Funding to Accelerate TechMed™ Platform Launch

Xenter announced the successful closing of its Series B financing round, raising $58.25 million. The funding will enable the company to accelerate the commercial launch of its XenFi™ platform, which is part of its broader efforts to expand its wireless medical device portfolio and advance its AI-Enabled Physical Intelligence™ platform. The company also expanded its board of directors with the appointment of financial executive Linda Vega, aiming to strengthen its strategic leadership. The financing round underscores investor confidence in Xenter's innovative medical technologies and growth potential in the healthcare sector. The company plans to utilize the funds to scale its operations, enhance product development, and expand market reach. This development is likely to positively influence investor sentiment towards Xenter and its associated technologies, signaling a strong push towards commercialization and innovation in medical tech.